- Cefpimizole
Drugbox
IUPAC_name = 2- [1-( [(6R,7R)-2-carboxy-7-( [(2R)-2- [(5-carboxy1H-imidazole-4-carbonyl)amino] -2-phenylacetyl] amino)-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-en-3-yl] methyl)pyridin-1-ium-4-yl] ethanesulfonate
width = 280
CAS_number = 84880-03-5
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 68597
DrugBank =
chemical_formula =
C=28 | H=26 | N=6 | O=10 | S=2
molecular_weight = 670.67 g/mol
smiles = C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)C4=C(NC=N4)C(=O)O)C(=O)O)C [N+] 5=CC=C(C=C5)CCS(=O)(=O) [O-]
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status = Rx-only
routes_of_administration =Cefpimizole (INN) is a third-generation
cephalosporin antibiotic .References
*cite journal |author=Hara K, Shimada J |title= [New antimicrobial agent series XXI: Cefpimizole] |language=Japanese |journal=Jpn J Antibiot |volume=40 |issue=6 |pages=1108–22 |year=1987 |month=June |pmid=3312705 |doi= |url=
Wikimedia Foundation. 2010.
